Cell Reprogramming Successes

Two studies demonstrate the first direct, chemical reprogramming of mouse and human skin cells into heart muscle and neural cells.

Written byCatherine Offord
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Neurons created from neural stem cells derived using a new direct cell reprogramming methodMINGLIANG ZHANG, PHD, GLADSTONE INSTITUTES (VIA EUREKALERT)Researchers have developed a method to directly reprogram cells using a combination of nine chemical compounds. The procedure bypasses the induced pluripotency step that has been used in previous chemical methods of cell reprogramming, as well as the gene introduction step that has been a focus of other attempts to reprogram cells directly. Led by stem cell biologist Sheng Ding at the Gladstone Institute of Cardiovascular Disease in San Francisco, the researchers demonstrated the procedure’s potential by reprogramming human skin cells into functional heart muscle and mouse skin cells into neural stem cells. The results were published last week (April 28) in Science and Cell Stem Cell, respectively.

“This method brings us closer to being able to generate new cells at the site of injury in patients,” Ding, who is also a professor at the University of California, San Francisco, said in a statement. “Our hope is to one day treat diseases like heart failure or Parkinson's disease with drugs that help the heart and brain regenerate damaged areas from their own existing tissue cells.”

In the Science study, Ding’s team used trial and error to find a combination of chemicals that could induce human skin cells to turn into multipotent stem cells, and then into cardiomyocytes. Honing the technique, the researchers were able to produce a population of cells that molecularly resembled heart muscle and developed into apparently healthy heart muscle when ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies